Health Ministry announced the results of medical examination of Russian citizens for 2023
26 February 2024
In 2023, Russia conducted clinical and preventive examinations, uncovering a staggering 17 million individuals (22%) who were deemed healthy. However, the most prevalent health classification among Russians, comprising 46% of the population, was Group III A. This category encompasses individuals who possess risk factors for non-communicable diseases, as highlighted by Valeria Gulshina, the Deputy Director of the Department of Medical Care and Sanatorium Affairs at the Russian Ministry of Health.
Clinical trials of a Russian drug against tick-borne encephalitis have been completed
22 February 2024
The drug created for the urgent treatment of tick-borne encephalitis has successfully finished its clinical trials, as declared by Vladimir Koval, the acting director of the Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the RAS.
New chemotherapy treatment could benefit multiple cancer types
22 February 2024
The innovative treatment significantly increased survival in patients with malignant pleural mesothelioma, a rare, aggressive cancer, according to Phase III data from UK researchers.
Raman and machine learning show promise for online monitoring of bioreactors
21 February 2024
The approach applied in the research on bioreactors represents a significant advancement over traditional methods, according to the researchers.
Sechenov University will use quantum technologies to accelerate drug development
21 February 2024
The drug created for the urgent treatment of tick-borne encephalitis has successfully finished its clinical trials, as declared by Vladimir Koval, the acting director of the Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the RAS.
Inhalable dry powder drug formulation could treat respiratory infections
20 February 2024
The drug formulation study offers promise for treating different respiratory tract infections using a single antimicrobial agent, a paper reports.
Smartphone app uses AI to potentially detect symptoms of stroke
20 February 2024
An artificial intelligence-enabled smartphone application developed to detect symptoms of stroke accurately evaluated facial asymmetry, arm weakness and speech changes in line with stroke onset, a speaker reported.
Clinical trials of a Russian drug against tick-borne encephalitis have been completed
19 February 2024
The drug created for the urgent treatment of tick-borne encephalitis has successfully finished its clinical trials, as declared by Vladimir Koval, the acting director of the Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the RAS.
Pharmaceutical suspension market to witness accelerated growth
19 February 2024
The global pharmaceutical suspensions market is set to value $83.8 billion by 2032, due to the systems having key benefits such as supporting patient compliance. A report by Allied Market Research predicts that the global pharmaceutical suspension market will reach $83.8 billion by 2032.
A genome database of 100 thousand Russians will be created by the end of 2025
16 February 2024
By the end of 2025, Russia will have a database of genomes of 100 thousand people. At the moment, the center for whole genome sequencing has a scientific database containing more than 27 thousand genomes. Andrey Shishkin, vice president for energy, localization, and innovation at Rosneft, stated that nearly all developed countries around the globe possess databases containing anywhere from 30,000 to half a million genomes. There is a discussion taking place about the potential for organizing extensive bioinformatics research in the Russian Federation. The research would focus on identifying genetic markers for diseases by utilizing anonymized data from a newly created genome database.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024